No abstract

We assessed the estrogen agonist activities of 21 parabens and their chlorinated derivatives by using yeast two-hybrid assays incorporating either the human or medaka (Oryzias latipes) estrogen receptor alpha (hERalpha and medERalpha, respectively), and by using hERalpha competitive enzyme-linked immunosorbent assay (ER-ELISA). In the two-hybrid assay with hERalpha, five parabens and three chlorinated derivatives exhibited estrogenic activity, and their relative activity (17beta-estradiol [E2] = 1) ranged from 2.0 x 10(-5) to 2.0 x 10(-4), with the highest activity observed in i-butylparaben. In the medERalpha assay, six parabens and six chlorinated derivatives exhibited estrogenic activity and their relative activity ranged from 2.7 x 10(-5) to 3.5 x 10(-3), with the highest activity observed in benzylparaben, its monochlorinated derivative, i-butylparaben, and n-butylparaben. Although medERalpha demonstrated an activity to E2 that was three times lower than that demonstrated by hERalpha, medERalpha has a higher sensitivity to parabens than hERa (1.3-8.9 times). Five parabens and two chlorinated derivatives exhibited a binding affinity to ERa in the ER-ELISA; of the parabens, i-butylparaben exhibited the strongest binding affinity. The yeast two-hybrid assay and the ER-ELISA also revealed that many of the assayed chlorinated parabens were much weaker than the parent compound. In addition, the results mainly showed that parabens with a bulk substituent (e.g., i-butyl and benzyl groups) had a higher activity than those with a sterically small substituent. It is considered that derivatization masks the apparent estrogenic activity of parabens, but the resulting chlorinated compounds may represent a potential hazard and therefore other toxicity tests should be performed to determine the toxicity of the chlorinated derivatives.

No abstract

We conducted feeding experiments on threadsail filefish Stephanolepis cirrhifer juveniles for 16 days to evaluate the efficacy of moon jellyfish Aurelia aurita as a prey item. Four treatments, each with 40 individuals, were prepared to compare fish growth performance. The treatments consisted of filefish that were starved (control) (S), fed only jellyfish (J), fed only krill (K), and fed both jellyfish and krill (JK). Fish in the S treatment exhibited a 50% mortality rate and reduced body weight, whereas the J treatment exhibited a zero mortality rate and increased body weight. Fish in the JK treatments showed a significantly faster growth than those in the K treatment. Filefish consumed as much as 24 and 13 times their own body weight in jellyfish per day in the J and JK treatments, respectively. This is the first report showing that growth can be sustained by feeding a marine fish only jellyfish, and indicates the potential of jellyfish as a fish prey in both nature and captivity.